Maria Ekdahl

All filings by Maria Ekdahl on record concern Infant Bacterial Therapeutics. Over a trading history stretching from 21 November 2022 to 14 November 2024, the count stands at 19 filings.

On the market, this insider has only ever bought: 16 purchases, €27k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2024 to date brings 4 purchases and no sales.

A typical purchase (the median) is worth €1,449. Of 16 purchases, 6 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 16 November 2024 with an open-market purchase (€1,464) in Infant Bacterial Therapeutics. The median gap between a trade and its publication by Finansinspektionen is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.